Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) reached a new 52-week low on Tuesday . The stock traded as low as $22.84 and last traded at $23.34, with a volume of 93783 shares. The stock had previously closed at $23.34.
Analyst Ratings Changes
XRAY has been the subject of several recent analyst reports. Needham & Company LLC lowered their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Wednesday. Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Barrington Research reiterated an “outperform” rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Finally, Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a report on Monday, July 22nd. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Moderate Buy” and an average price target of $31.88.
Read Our Latest Report on DENTSPLY SIRONA
DENTSPLY SIRONA Price Performance
Hedge Funds Weigh In On DENTSPLY SIRONA
A number of institutional investors have recently bought and sold shares of the business. AM Squared Ltd increased its holdings in shares of DENTSPLY SIRONA by 69.4% during the 3rd quarter. AM Squared Ltd now owns 6,100 shares of the medical instruments supplier’s stock worth $165,000 after acquiring an additional 2,500 shares during the last quarter. Natixis Advisors LLC raised its position in shares of DENTSPLY SIRONA by 21.1% in the third quarter. Natixis Advisors LLC now owns 21,733 shares of the medical instruments supplier’s stock valued at $588,000 after purchasing an additional 3,787 shares during the period. Empowered Funds LLC acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth about $2,468,000. Connable Office Inc. lifted its position in DENTSPLY SIRONA by 16.4% during the third quarter. Connable Office Inc. now owns 15,150 shares of the medical instruments supplier’s stock worth $410,000 after acquiring an additional 2,138 shares during the last quarter. Finally, KBC Group NV grew its holdings in DENTSPLY SIRONA by 19.9% in the 3rd quarter. KBC Group NV now owns 6,274 shares of the medical instruments supplier’s stock valued at $170,000 after buying an additional 1,040 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More
- Five stocks we like better than DENTSPLY SIRONA
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 2 Online Educational Platforms Staging a Turnaround
- The Role Economic Reports Play in a Successful Investment Strategy
- Top 3 Sectors Outperforming After Trump’s Victory
- Roth IRA Calculator: Calculate Your Potential Returns
- Sono-Tek’s $2M Buyback: A Buying Opportunity in Clean Tech
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.